Health Condition 1: I499- Cardiac arrhythmia, unspecified Health Condition 2: null- Post cardiac surgery patients with Junctional Ectopic Tachycardia
Conditions
Interventions
Intervention1: Ivabradine: A oral drug used in management of Heart failure and sinus tachycardia
Control Intervention1: Amiodarone: Drug which has been used in the management of JET , with variable de
Sponsors
AIIMS
Eligibility
Inclusion criteria
Inclusion criteria: 1.Pediatric Patients who undergo corrective Open Heart surgery for various congenital heart diseases electively (Age 2.Patients who develop JET until 1 month of surgery 3. Parents/ Guardians of the children giving written informed consent
Exclusion criteria
Exclusion criteria: 1 Patients who have Preoperative arrhythmias or who are already on Anti- arrhythmics 2 Preoperative hospital stay > 7 days 3 Severe Liver Dysfunction 4 Multi Organ Dysfunction 5 Parents/ Guardians not giving written consent for inclusion in the trial 6 All emergency surgeries 7 All closed heart surgeries
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Restoration of normal sinus rhythm Timepoint: Upto 48 hour after institution of therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes: 1. Controlling of heart rate to age acceptable levels (140 bpm (in upto 3 months),120 bpm in 3months â?? 2 years and 100 bpm in older children) that allows hemodynamic improvement with/without atrial or AV sequential pacing 2. Time taken to achieve NSR/ Rate control Timepoint: Upto 48 hour after institution of therapy | — |
Countries
India
Contacts
Public ContactArvind B
Department of Cardiology, AIIMS, New Delhi
Outcome results
None listed